Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Patient-specific dose escalation during brachytherapy using multiparametric MRI in cervical cancer

EF 2021-22

Résumé
Cervical cancer is the fourth most common cancer in females worldwide. Standard treatment for locally advanced cervical cancer is the combined use of radiation therapy and chemotherapy. Radiation kills cancer cells by damaging their DNA. Brachytherapy, a type of radiation therapy used in the treatment of cervical cancer, delivers radiation internally to the body which allows a high dose of radiation to be directly applied to the tumours and a relatively low dose to other organs. The main goal of treatment is to improve survival and quality of life.Further improvements can be made by adapting dose to the specific properties of a patients tumour. Response to radiation therapy can vary between individual tumours based on the presence of oxygen. Hypoxic tumours (those lacking sufficient oxygen) are known to be more resistant to the effects of radiation. However, high doses of radiation can counteract this. In order to individualize care, we must be able to image these hypoxic regions. Two types of magnetic resonance imaging (diffusion-weighted and dynamic contrast-enhanced) have been linked to the identification of hypoxic regions.Here we aim to demonstrate the ability to image and identify these hypoxic regions at the time of treatment. Once successfully identified, we will evaluate the ability to increase radiation to these regions to counteract the effects of hypoxia. We will also design a new applicator with a high-resolution grid with the aim of more accurate dose delivery and compare its ability to accurately deliver high doses of radiation to hypoxic regions against that of a standard, commercially available brachytherapy applicator. Ultimately, we aim to improve survival and quality of life for cervical cancer patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466999
Name
Umolac Troy M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Patient-specific dose escalation during brachytherapy using multiparametric MRI in cervical cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brachytherapy; Cervical Cancer; Dose Escalation; Hypoxia; Magnetic Resonance Imaging; Multiparametric Imaging; Radioresistance
Abstract
Cervical cancer is the fourth most common cancer in females worldwide. Standard treatment for locally advanced cervical cancer is the combined use of radiation therapy and chemotherapy. Radiation kills cancer cells by damaging their DNA. Brachytherapy, a type of radiation therapy used in the treatment of cervical cancer, delivers radiation internally to the body which allows a high dose of radiation to be directly applied to the tumours and a relatively low dose to other organs. The main goal of treatment is to improve survival and quality of life.Further improvements can be made by adapting dose to the specific properties of a patients tumour. Response to radiation therapy can vary between individual tumours based on the presence of oxygen. Hypoxic tumours (those lacking sufficient oxygen) are known to be more resistant to the effects of radiation. However, high doses of radiation can counteract this. In order to individualize care, we must be able to image these hypoxic regions. Two types of magnetic resonance imaging (diffusion-weighted and dynamic contrast-enhanced) have been linked to the identification of hypoxic regions.Here we aim to demonstrate the ability to image and identify these hypoxic regions at the time of treatment. Once successfully identified, we will evaluate the ability to increase radiation to these regions to counteract the effects of hypoxia. We will also design a new applicator with a high-resolution grid with the aim of more accurate dose delivery and compare its ability to accurately deliver high doses of radiation to hypoxic regions against that of a standard, commercially available brachytherapy applicator. Ultimately, we aim to improve survival and quality of life for cervical cancer patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Umolac, Troy M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~